Hou Haifeng, M.D., Ph.D.

Department:Nuclear Medicine and PET-CT Center

Medical School:Peking University, China

Academic Rank:Associate Chief Physician


Clinical / Research Interests

Molecular imaging, PET/CT and SPECT imaging diagnosis, radionuclide therapy.

Professional Highlights

Professional Appointments

Member, Zhejiang Society of Nuclear Medicine

Education Experience

Research Summary


Hou H, Qing Z, Jia S*, Zhang X, Hu S, Hu J. Influence of brain-derived neurotrophic factor (val66met) genetic polymorphism on the ages of onset for heroin abuse in males. Brain Res, 1353:245-248, 2010.

Hou H, Yin S, Jia S*, Hu S, Sun T, Chen Q, Fan R. Decreased striatal dopamine transporters in codeine-containing cough syrup abusers. Drug Alcohol Depend, 118(2-3):148-151, 2011.

Hou H, Tian M, Zhang H*. Positron emission tomography molecular imaging of dopaminergic system in drug addiction. Anat Rec (Hoboken), 295(5):722-733, 2012.

Hou H, Jia S, Hu S, Fan R, Sun W, Sun T, Zhang H*. Reduced striatal dopamine transporters in people with internet addiction disorder. J Biomed Biotechnol, 2012:854524, 2012.

Hou H#, Wang C#, Jia S, Hu S, Tian T*. Brain dopaminergic system changes in drug addiction: a review of positron emission tomography findings.Neurosci Bull, 30(5):765-776, 2014.

Hou H, Hu S, Fan R, Sun W, Zhang X, Tian M*. Prognostic value of Tc99m-pertechnetate thyroid scintigraphy in radioiodine therapy in a cohort of Chinese Graves’ disease patients: a pilot clinical study. Biomed Res Int, 2015:974689, 2015.

Dong Y#, Hou H#* Wang C, Li J, Yao Q, Amer S, Tian M*. Diagnostic value of 18F-FDG PET/CT in association with serum tumor marker assays in breast cancer recurrence and metastasis. Biomed Res Int, 2015:489021, 2015.

Current Program

Find People

Search by Family Name

Find A Department

Search by Departments